CHE | Ticker Profile - Titan Protect

CHE

Chemed Corporation

Healthcare · Medical Care Facilities · NYQ

$441.59

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$5.8B

Total market value of the company

Trailing P/E

23.99

Premium valuation

Forward P/E

16.33

Based on estimated future earnings — lower means cheaper

Rev Growth

+1.6%

Year-over-year revenue change

Profit Margin

10.2%

How much profit the company keeps from each dollar of revenue

ROE

25.6%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$443.00

+0% from current price — median analyst estimate

Recommendation

BUY

Consensus view from 4 analysts covering this stock

About Chemed Corporation

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

https://www.chemed.com

Country: United States Employees: 15,811 Industry: Medical Care Facilities

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

ACCUMULATION

Smart money appears to be building positions quietly

Sharpe Ratio

-0.190

Returns do not compensate for the risk — negative edge

Kelly Fraction

-0.0214

No positive edge detected — the data suggests staying out

Calmar Ratio

-0.234

Drawdown risk outweighs the returns — higher risk profile

Annual Return

-9.4%

Historical annualised return based on price data

Max Drawdown

-40.2%

Largest peak-to-trough decline — the worst it has been

HMM State

SIDEWAYS

Price consolidating — no clear directional bias

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.54

Less volatile than the market — more defensive

52W High

$578.57

24% below the year high

52W Low

$365.21

21% above the year low

Avg Volume

262,116

Average daily shares traded — higher means easier to buy and sell

Short Ratio

2.4

Days it would take all short sellers to cover — higher means more crowded

Short % Float

5.6%

Moderate short interest

Div Yield

55.0%

Annual dividend as a percentage of the share price

EPS (TTM)

$18.32

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

27.94

Heavy leverage — higher financial risk if revenues decline

Current Ratio

0.85

Below 1 means short-term obligations exceed liquid assets — risk flag

Quick Ratio

0.72

Like current ratio but excludes inventory — stricter test

Gross Margin

32.4%

Revenue left after cost of goods — higher means pricing power

Operating Margin

12.9%

Profit from core operations before interest and tax

Free Cash Flow

$348M

Positive — the business generates more cash than it spends

Revenue (TTM)

$2.5B

Total revenue over the last 12 months

Net Income

$260M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$500.00

Target Median

$443.00

Target Low

$400.00

Political Trading Activity

Congressional trading disclosures involving this instrument

Date	Politician	Party	Type	Amount
7 Feb2025	Tim Walberg	Republican	buy	15K–50K
2026-04-14	Scott Peters	Democrat	Purchase	50K–100K
2026-04-13	Ro Khanna	Democrat	Purchase	1K–15K
2026-04-13	Ro Khanna	Democrat	Purchase	1K–15K
14 Apr2026	Scott Peters	Democrat	buy	50K–100K

Source: Congressional disclosure filings. View all political trades at

Insider Intelligence

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go